Stock listing
NASDAQ:TNGX Tango Therapeutics, Inc. Stock
Home listing (NASDAQ) of Tango Therapeutics, Inc.
Follow Tango Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TNGX
$21.76 USD -0.96 (-4.2%)
Close on Nov 2, 2026
- Day range
- $21.72 – $23.31 USDNov 2, 2026
- Volume
- 3.68M sharesNov 2, 2026
- Market cap
- $3.67B USDAt the close on Nov 2, 2026 · price × 168.6M shares outstanding
- 52-week range
- $7.37 – $34.39 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $78.60M USDMedian day 2.56M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TNGX · Home | $21.76 USD | -0.96 (-4.2%) | 3,681,587 | $22.65 | $23.31 | $21.72 | $22.72 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TNGX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $21.76 | -0.96 | -4.2% | $22.65 | $23.31 | $21.72 | 3,681,587 | |
| $22.72 | +0.19 | +0.8% | $22.11 | $22.75 | $21.71 | 5,279,230 | |
| $22.53 | +0.30 | +1.3% | $22.36 | $23.58 | $22.36 | 3,369,953 | |
| $22.23 | -0.66 | -2.9% | $22.86 | $23.71 | $22.14 | 3,309,657 | |
| $22.89 | +0.695 | +3.1% | $22.02 | $23.50 | $21.81 | 3,322,765 | |
| $22.20 | -1.145 | -4.9% | $23.41 | $23.95 | $22.00 | 5,370,456 | |
| $23.34 | -4.59 | -16.4% | $25.54 | $25.94 | $22.68 | 15,852,900 | |
| $27.93 | +0.95 | +3.5% | $26.67 | $27.98 | $25.94 | 5,964,100 | |
| $26.98 | +1.73 | +6.9% | $25.55 | $27.60 | $25.35 | 5,557,300 | |
| $25.25 | +1.72 | +7.3% | $23.95 | $25.35 | $23.20 | 2,673,700 | |
| $23.53 | +1.49 | +6.8% | $22.49 | $23.86 | $22.36 | 1,870,800 | |
| $22.04 | -0.66 | -2.9% | $23.12 | $23.17 | $21.82 | 3,688,300 | |
| $22.70 | +0.51 | +2.3% | $22.27 | $22.96 | $21.79 | 2,903,900 | |
| $22.19 | -0.03 | -0.1% | $21.98 | $23.02 | $21.52 | 3,438,800 | |
| $22.22 | -1.95 | -8.1% | $23.85 | $24.11 | $21.85 | 9,619,100 | |
| $24.17 | +0.36 | +1.5% | $23.57 | $24.47 | $23.34 | 2,868,000 | |
| $23.81 | +1.24 | +5.5% | $22.60 | $24.12 | $22.44 | 3,098,800 | |
| $22.57 | +0.74 | +3.4% | $21.57 | $22.68 | $20.98 | 5,074,400 | |
| $21.83 | -0.07 | -0.3% | $21.64 | $22.46 | $21.38 | 3,392,800 | |
| $21.90 | -1.18 | -5.1% | $23.16 | $23.16 | $21.36 | 4,351,000 | |
| $23.08 | -0.16 | -0.7% | $23.29 | $23.56 | $22.25 | 1,943,900 | |
| $23.24 | -1.21 | -4.9% | $25.09 | $25.09 | $23.09 | 5,253,600 | |
| $24.45 | -0.50 | -2.0% | $24.90 | $25.43 | $23.95 | 2,910,300 | |
| $24.95 | +0.53 | +2.2% | $24.64 | $25.41 | $23.82 | 3,660,500 | |
| $24.42 | +0.12 | +0.5% | $24.32 | $24.80 | $23.18 | 2,992,200 | |
| $24.30 | -0.62 | -2.5% | $24.92 | $24.92 | $23.70 | 2,413,400 | |
| $24.92 | +0.29 | +1.2% | $24.95 | $25.38 | $24.08 | 3,255,000 | |
| $24.63 | +0.18 | +0.7% | $23.99 | $24.83 | $23.50 | 2,290,600 | |
| $24.45 | -1.08 | -4.2% | $25.40 | $25.92 | $24.06 | 4,957,100 | |
| $25.53 | +3.20 | +14.3% | $22.33 | $25.75 | $22.25 | 6,968,700 | |
| $22.33 | +0.58 | +2.7% | $21.90 | $22.74 | $21.63 | 2,555,300 | |
| $21.75 | -1.74 | -7.4% | $23.33 | $23.55 | $21.72 | 6,242,500 | |
| $23.49 | +0.14 | +0.6% | $23.79 | $24.63 | $23.41 | 1,721,900 | |
| $23.35 | -0.54 | -2.3% | $24.17 | $24.39 | $23.00 | 2,835,500 | |
| $23.89 | -0.65 | -2.6% | $24.55 | $24.55 | $23.59 | 1,791,000 | |
| $24.54 | +0.76 | +3.2% | $23.98 | $24.99 | $23.44 | 2,010,900 | |
| $23.78 | +0.41 | +1.8% | $23.72 | $24.63 | $23.19 | 2,279,300 | |
| $23.37 | -0.63 | -2.6% | $23.16 | $24.30 | $23.16 | 3,437,300 | |
| $24.00 | +1.30 | +5.7% | $22.99 | $25.52 | $22.63 | 4,664,500 | |
| $22.70 | +0.18 | +0.8% | $22.50 | $23.08 | $22.26 | 2,424,800 | |
| $22.52 | -0.24 | -1.1% | $22.48 | $22.94 | $22.29 | 1,457,400 | |
| $22.76 | +0.44 | +2.0% | $22.50 | $22.79 | $22.13 | 1,343,700 | |
| $22.32 | -0.03 | -0.1% | $22.62 | $23.12 | $21.64 | 1,916,400 | |
| $22.35 | -0.49 | -2.1% | $22.60 | $23.06 | $22.07 | 1,544,300 | |
| $22.84 | -0.50 | -2.1% | $23.28 | $23.50 | $22.61 | 1,850,100 | |
| $23.34 | -1.94 | -7.7% | $24.93 | $25.09 | $23.28 | 1,999,000 | |
| $25.28 | -0.19 | -0.7% | $25.39 | $26.85 | $25.24 | 2,037,400 | |
| $25.47 | +0.70 | +2.8% | $24.65 | $27.00 | $24.26 | 3,173,900 | |
| $24.77 | +0.26 | +1.1% | $25.04 | $25.61 | $24.35 | 2,283,248 | |
| $24.51 | +0.63 | +2.6% | $23.60 | $24.68 | $22.91 | 2,088,761 | |
| $23.88 | +0.37 | +1.6% | $23.95 | $24.36 | $23.48 | 2,488,700 | |
| $23.51 | -1.69 | -6.7% | $25.51 | $25.67 | $23.15 | 2,064,600 | |
| $25.20 | -0.24 | -0.9% | $26.19 | $26.34 | $25.01 | 1,823,700 | |
| $25.44 | +0.15 | +0.6% | $25.00 | $25.95 | $24.97 | 2,277,900 | |
| $25.29 | -0.31 | -1.2% | $25.64 | $25.93 | $25.12 | 2,228,800 | |
| $25.60 | -0.05 | -0.2% | $25.21 | $25.70 | $24.75 | 1,439,200 | |
| $25.65 | +0.07 | +0.3% | $25.85 | $25.95 | $25.38 | 2,169,300 | |
| $25.58 | -0.76 | -2.9% | $26.08 | $26.84 | $25.50 | 2,433,700 | |
| $26.34 | -1.33 | -4.8% | $27.05 | $27.53 | $26.15 | 2,260,600 | |
| $27.67 | +0.60 | +2.2% | $26.90 | $28.09 | $26.70 | 2,550,600 | |
| $27.07 | -1.93 | -6.7% | $28.71 | $29.24 | $26.75 | 3,230,800 | |
| $29.00 | +0.21 | +0.7% | $28.28 | $30.10 | $28.28 | 1,317,600 | |
| $28.79 | -0.57 | -1.9% | $29.42 | $30.25 | $28.00 | 1,861,300 | |
| $29.36 | +2.15 | +7.9% | $27.74 | $29.43 | $27.54 | 1,870,000 | |
| $27.21 | +0.03 | +0.1% | $26.83 | $27.79 | $25.94 | 1,981,300 |
- Ticker
- NASDAQ:TNGX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 23, 2026
Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy
Latest deck · Oct 23, 2026
PDAC Investor Presentation (October 2026)
Conference · 35 slides
Latest news
Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy
Oct 23, 2026
Closed $23.34 (-16.4%) on Oct 23, 2026
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
Oct 16, 2026
Closed $22.04 (-2.9%) on Oct 16, 2026
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 3, 2026
Closed $22.52 (-1.1%) on Sep 4, 2026
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Sep 1, 2026
Closed $22.35 (-2.1%) on Sep 1, 2026
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Aug 11, 2026
Closed $26.34 (-4.8%) on Aug 11, 2026
Tango Therapeutics Announces Executive Chair Transition
Aug 6, 2026
Closed $27.07 (-6.7%) on Aug 7, 2026
Tango Therapeutics Appoints Robert Azelby to Board of Directors
Jun 22, 2026
Closed $28.39 (-0.4%) on Jun 23, 2026
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
Jun 9, 2026
Closed $28.68 (-9.1%) on Jun 10, 2026
Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
Jun 8, 2026
Closed $30.93 (+53.0%) on Jun 8, 2026
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
May 13, 2026
Closed $24.87 (-2.5%) on May 14, 2026
Decks
PDAC Investor Presentation (October 2026)
Conference · 35 slides · Oct 23, 2026
PDAC Investor Presentation (October 2026)
Conference · 35 slides · Oct 23, 2026
Investor Presentation (August 2026)
Investor deck · 36 slides · August 2026
Technical Presentation (June 2026)
Technical · 31 slides · Jun 8, 2026
Tango Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 89 in all · newest Oct 23, 2026 · oldest 2021
- Decks
- 15 decks · latest Oct 23, 2026
Where Tango Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TNGX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TNGX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Tango Therapeutics, Inc.